Pediatric and Neonatal Dosage Handbook
Description:
Overview
The Lexicomp Pediatric & Neonatal Dosage Handbook, 25th edition, is a valuable point-of-care dosing resource designed to support medical professionals managing pediatric and neonatal patients.
Benefits
The Pediatric & Neonatal Dosing Handbook includes more than 1,000 drug monographs featuring concise fields of information specific to neonates and children. It follows a convenient, dictionary-like format, with drug products alphabetically organized and cross-referenced by U.S. and Canadian brand names.
Clear, concise and relevant Lexicomp drug information is supplemented by an extensive Appendix of comparative charts, tables and supportive information, as well as a Therapeutic Category & Key Word Index.
Includes:
- 1121 drug monographs
- Up to 45 Fields of Information per Monograph
- More than 150 Extemporaneous Preparation Recipes
- More than 120 Pages of Appendix Information
Updates to this Edition:
- 39 New Drug Monographs
- New Fields of Information:
> Dosing: Renal Impairment: Pediatric
> Dosing: Hepatic Impairment: Pediatric
> Pharmacodynamics/Kinetics: Additional Considerations
- Updates to Hundreds of Existing Monographs, Including Updates Based on New Guideline Recommendations
- Updated Appendix Topics:
> Corticosteroids Systemic Equivalencies
> Normal Pediatric Heart Rates (PALS 2016)
Best prices to buy, sell, or rent ISBN 9781591953746
Frequently Asked Questions about Pediatric and Neonatal Dosage Handbook
The price for the book starts from $84.97 on Amazon and is available from 14 sellers at the moment.
If you’re interested in selling back the Pediatric and Neonatal Dosage Handbook book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Pediatric and Neonatal Dosage Handbook book, the best buyback offer comes from and is $ for the book in good condition.
The Pediatric and Neonatal Dosage Handbook book is in very low demand now as the rank for the book is 821,485 at the moment. It's a very low rank, and the book has minimal sales on Amazon.
Not enough insights yet.